5-Substituted isatin thiosemicarbazones as inhibitors of tyrosinase: Insights of substituent effects. 2021

Run Cheng, and Wenyan Shi, and Qingyun Yuan, and Ruiren Tang, and Yujie Wang, and Di Yang, and Xin Xiao, and Jianping Zeng, and Jingwen Chen, and Yanqing Wang
College of Chemistry and Chemical Engineering, Central South University, Changsha 410000, PR China; School of Chemistry and Chemical Engineering, Building Materials Research Academy, Yancheng Institute of Technology, Jianjun East Rd. 211, Yancheng 224051, PR China.

Seven isatin-thiosemicarbazone analogues bearing different substituents (R) attached at C-5 of the indoline ring, TSC-ISA-R (R = -H, -CH3, -OCH3, -OCF3, -F, -Cl and -NO2), were synthesized and evaluated as inhibitors of mushroom tyrosinase (TYR). The inhibitory behaviour and performance of TSC-ISA-R were investigated spectroscopically in relation to the substituent modifications through examining their inhibition against the diphenolase activity of TYR using L-DOPA as a substrate. The IC50 values of TSC-ISA-R were determined to be in the range of 81-209 μM. The kinetic analysis showed that TSC-ISA-R were reversible and mixed type inhibitors. Three potential non-covalent interactions rather than complexation including the binding of TSC-ISA-R with free TYR, TYR-L-DOPA complex, and with substrate L-DOPA were found to be involved in the inhibition. The substituent modifications affected these interactions by varying the characters of the resulting TSC-ISA-R in different degrees. The thiosemicarbazido moiety of each TSC-ISA-R contributed predominantly to the inhibition, and the isatin moiety seemed to play a regulatory role in the binding of TSC-ISA-R to the target molecules. The results of theoretical calculations using density functional theory method indicated a different effect of -R on the electron distribution in HOMO of TSC-ISA-R. The LUMO-HOMO energy gap of TSC-ISA-R almost accords with the trend of their experimental inhibition potency.

UI MeSH Term Description Entries
D007510 Isatin An indole-dione that is obtained by oxidation of indigo blue. It is a MONOAMINE OXIDASE INHIBITOR and high levels have been found in urine of PARKINSONISM patients. 2,3-Dioxoindoline,2,3 Dioxoindoline
D007700 Kinetics The rate dynamics in chemical or physical systems.
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000363 Agaricales An extensive order of basidiomycetous fungi whose fruiting bodies are commonly called mushrooms. Agaricaceae,Mushrooms,Agaricale,Mushroom
D013882 Thiosemicarbazones Thiosemicarbazone
D014442 Monophenol Monooxygenase An enzyme of the oxidoreductase class that catalyzes the reaction between L-tyrosine, L-dopa, and oxygen to yield L-dopa, dopaquinone, and water. It is a copper protein that acts also on catechols, catalyzing some of the same reactions as CATECHOL OXIDASE. EC 1.14.18.1. Dopa Oxidase,Phenoloxidase,Tyrosinase,Cresolase,Phenol Oxidase,Phenoloxidase A,Phenoloxidase B,Monooxygenase, Monophenol,Oxidase, Dopa,Oxidase, Phenol

Related Publications

Run Cheng, and Wenyan Shi, and Qingyun Yuan, and Ruiren Tang, and Yujie Wang, and Di Yang, and Xin Xiao, and Jianping Zeng, and Jingwen Chen, and Yanqing Wang
August 2017, Bioorganic & medicinal chemistry letters,
Run Cheng, and Wenyan Shi, and Qingyun Yuan, and Ruiren Tang, and Yujie Wang, and Di Yang, and Xin Xiao, and Jianping Zeng, and Jingwen Chen, and Yanqing Wang
April 2011, Bioorganic & medicinal chemistry letters,
Run Cheng, and Wenyan Shi, and Qingyun Yuan, and Ruiren Tang, and Yujie Wang, and Di Yang, and Xin Xiao, and Jianping Zeng, and Jingwen Chen, and Yanqing Wang
November 2007, Natural product research,
Run Cheng, and Wenyan Shi, and Qingyun Yuan, and Ruiren Tang, and Yujie Wang, and Di Yang, and Xin Xiao, and Jianping Zeng, and Jingwen Chen, and Yanqing Wang
January 2020, Food chemistry,
Run Cheng, and Wenyan Shi, and Qingyun Yuan, and Ruiren Tang, and Yujie Wang, and Di Yang, and Xin Xiao, and Jianping Zeng, and Jingwen Chen, and Yanqing Wang
January 2020, Bioorganic chemistry,
Run Cheng, and Wenyan Shi, and Qingyun Yuan, and Ruiren Tang, and Yujie Wang, and Di Yang, and Xin Xiao, and Jianping Zeng, and Jingwen Chen, and Yanqing Wang
August 1984, Archiv der Pharmazie,
Run Cheng, and Wenyan Shi, and Qingyun Yuan, and Ruiren Tang, and Yujie Wang, and Di Yang, and Xin Xiao, and Jianping Zeng, and Jingwen Chen, and Yanqing Wang
June 2011, Biochimica et biophysica acta,
Run Cheng, and Wenyan Shi, and Qingyun Yuan, and Ruiren Tang, and Yujie Wang, and Di Yang, and Xin Xiao, and Jianping Zeng, and Jingwen Chen, and Yanqing Wang
August 1973, Antimicrobial agents and chemotherapy,
Run Cheng, and Wenyan Shi, and Qingyun Yuan, and Ruiren Tang, and Yujie Wang, and Di Yang, and Xin Xiao, and Jianping Zeng, and Jingwen Chen, and Yanqing Wang
May 1985, Archiv der Pharmazie,
Run Cheng, and Wenyan Shi, and Qingyun Yuan, and Ruiren Tang, and Yujie Wang, and Di Yang, and Xin Xiao, and Jianping Zeng, and Jingwen Chen, and Yanqing Wang
March 2012, European journal of medicinal chemistry,
Copied contents to your clipboard!